Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Jul 11, 2023

SELL
$1.66 - $3.67 $2,324 - $5,138
-1,400 Reduced 2.59%
52,600 $92,000
Q4 2022

May 17, 2023

BUY
$2.77 - $5.07 $12,742 - $23,322
4,600 Added 9.31%
54,000 $170 Million
Q3 2022

May 16, 2023

BUY
$4.27 - $6.39 $210,937 - $315,666
49,400 New
49,400 $242 Million
Q4 2021

Feb 03, 2022

SELL
$7.29 - $10.97 $262,440 - $394,920
-36,000 Closed
0 $0
Q3 2021

Oct 21, 2021

SELL
$9.01 - $12.01 $86,496 - $115,296
-9,600 Reduced 21.05%
36,000 $324,000
Q2 2021

Aug 13, 2021

SELL
$10.17 - $12.64 $19,323 - $24,016
-1,900 Reduced 4.0%
45,600 $546,000
Q1 2021

Apr 30, 2021

BUY
$10.88 - $17.05 $96,832 - $151,745
8,900 Added 23.06%
47,500 $595,000
Q4 2020

Feb 16, 2021

BUY
$9.23 - $18.18 $95,069 - $187,254
10,300 Added 36.4%
38,600 $602,000
Q3 2020

Nov 12, 2020

BUY
$9.38 - $12.48 $11,256 - $14,976
1,200 Added 4.43%
28,300 $267,000
Q2 2020

Aug 12, 2020

BUY
$6.21 - $11.83 $68,310 - $130,130
11,000 Added 68.32%
27,100 $243,000
Q1 2020

May 12, 2020

BUY
$5.05 - $8.85 $81,305 - $142,485
16,100 New
16,100 $103,000
Q4 2019

Jan 27, 2020

SELL
$8.03 - $11.7 $172,645 - $251,549
-21,500 Closed
0 $0
Q3 2019

Oct 22, 2019

BUY
$9.05 - $12.22 $5,430 - $7,332
600 Added 2.87%
21,500 $195,000
Q2 2019

Jul 26, 2019

BUY
$8.75 - $13.03 $21,875 - $32,575
2,500 Added 13.59%
20,900 $225,000
Q1 2019

Apr 25, 2019

SELL
$7.72 - $12.81 $193,772 - $321,531
-25,100 Reduced 57.7%
18,400 $176,000
Q4 2018

Feb 07, 2019

BUY
$9.51 - $16.6 $33,285 - $58,100
3,500 Added 8.75%
43,500 $499,000
Q3 2018

Nov 02, 2018

BUY
$13.05 - $19.05 $522,000 - $762,000
40,000 New
40,000 $678,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $180M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.